Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidiolex in Tuberous Sclerosis Complex
NCT02544763Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Apr 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of cannabidiol in tuberous sclerosis complex (TSC), sponsored by Jazz Pharmaceuticals plc. Started Apr 2016; status: completed.
02
Drugs
cannabidiol
03
Conditions
tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on NCT02544763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02544763.